201 related articles for article (PubMed ID: 10646119)
1. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover.
Angel NZ; Walsh N; Forwood MR; Ostrowski MC; Cassady AI; Hume DA
J Bone Miner Res; 2000 Jan; 15(1):103-10. PubMed ID: 10646119
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
3. Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice.
Pan W; Mathews W; Donohue JM; Ramnaraine ML; Lynch C; Selski DJ; Walsh N; Cassady AI; Clohisy DR
J Biol Chem; 2005 Feb; 280(6):4888-93. PubMed ID: 15590658
[TBL] [Abstract][Full Text] [Related]
4. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
[TBL] [Abstract][Full Text] [Related]
5. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
6. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.
Walsh NC; Cahill M; Carninci P; Kawai J; Okazaki Y; Hayashizaki Y; Hume DA; Cassady AI
Gene; 2003 Mar; 307():111-23. PubMed ID: 12706893
[TBL] [Abstract][Full Text] [Related]
7. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
10. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.
Perez-Amodio S; Jansen DC; Schoenmaker T; Vogels IM; Reinheckel T; Hayman AR; Cox TM; Saftig P; Beertsen W; Everts V
Calcif Tissue Int; 2006 Oct; 79(4):245-54. PubMed ID: 17033726
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy.
Hayman AR
Autoimmunity; 2008 Apr; 41(3):218-23. PubMed ID: 18365835
[TBL] [Abstract][Full Text] [Related]
12. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
13. Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.
Rice DP; Kim HJ; Thesleff I
Bone; 1997 Dec; 21(6):479-86. PubMed ID: 9430236
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter.
Reddy SV; Hundley JE; Windle JJ; Alcantara O; Linn R; Leach RJ; Boldt DH; Roodman GD
J Bone Miner Res; 1995 Apr; 10(4):601-6. PubMed ID: 7610931
[TBL] [Abstract][Full Text] [Related]
15. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation.
Partington GA; Fuller K; Chambers TJ; Pondel M
Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802
[TBL] [Abstract][Full Text] [Related]
16. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.
Costa D; Lazzarini E; Canciani B; Giuliani A; Spanò R; Marozzi K; Manescu A; Cancedda R; Tavella S
J Cell Physiol; 2013 Nov; 228(11):2210-21. PubMed ID: 23606520
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice that express Cre recombinase in osteoclasts.
Chiu WS; McManus JF; Notini AJ; Cassady AI; Zajac JD; Davey RA
Genesis; 2004 Jul; 39(3):178-85. PubMed ID: 15282744
[TBL] [Abstract][Full Text] [Related]
18. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues.
Hayman AR; Bune AJ; Bradley JR; Rashbass J; Cox TM
J Histochem Cytochem; 2000 Feb; 48(2):219-28. PubMed ID: 10639488
[TBL] [Abstract][Full Text] [Related]
19. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
